or
Remember me
Back
Endo pays the bills for the trial, but Bioniche has had to pay the cost for manufacturing all the Urocidin necessary used in the trial up to this point, which is considerable with respect to cash on hand.
Receive investor kits and email updates from Stockhouse and directly from these companies.